# A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants

> **NCT06145178** · PHASE1 · COMPLETED · sponsor: **SpyBiotech Limited** · enrollment: 120 (actual)

## Conditions studied

- Cytomegalovirus Infections

## Interventions

- **BIOLOGICAL:** SPYVAC01

## Key facts

- **NCT ID:** NCT06145178
- **Lead sponsor:** SpyBiotech Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-22
- **Primary completion:** 2025-06-20
- **Final completion:** 2025-07-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06145178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06145178, "A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06145178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*